1. Noninvasive blood test uses methylation patterns in cell-free DNA to detect liver allograft injury.
2. Identifies specific liver cell damage and provides a clearer view of transplant's condition.
3. Could complement or reduce the need for invasive liver biopsies.
4. Test offers precision monitoring after liver transplantation.
5. Larger studies needed to confirm findings and guide clinical integration.

Source: Nature Communications